Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Japanese society of Hematology, clinical practice guideline. (in Japanese). http://www.jshem.or.jp/gui-hemali/table.html . Accessed March 2016.
2. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Multiple Myeloma (V.2.2010). Fort Washington, PA: NCCN. 2010.
3. Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, et al. Medical Research Council Adult Leukaemia Working Party. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med. 2003;348:1875–83.
4. Fermand JP, Katsahian S, Divine M, Leblond V, Dreyfus F, Macro M, Group Myelome-Autogreffe, et al. High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe. J Clin Oncol. 2005;23:9227–33.
5. Sung AD, Grima DT, Bernard LM, Brown S, Carrum G, Holmberg L, et al. Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone. Bone Marrow Transpl. 2013;48:1444–9.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献